Days
Hours
Minutes
Seconds
-40%
on all subscriptions*
Last days
Enjoy this offer
* See conditions under "Our services"

Valuation: Vineet Laboratories Limited

Market Cap 558M 5.87M 5.07M 4.67M 4.38M 8.21M 8.33M 55.38M 21.55M 271M 22.03M 21.56M 941M P/E Ratio 2024
43.6x
P/E Ratio 2025 -1.42x
Enterprise Value 956M 10.05M 8.68M 8M 7.5M 14.06M 14.27M 94.82M 36.89M 465M 37.71M 36.9M 1.61B EV / Sales 2024
587,502x
EV / Sales 2025 890,202x
Free-Float
62.66%
Yield 2024 *
-
Yield 2025 -
1 day-1.54%
1 week-2.30%
1 month-6.85%
3 months+13.08%
6 months-20.89%
Current year-7.64%
1 week 33.06
Extreme 33.06
34.9
1 month 32.76
Extreme 32.76
37.4
Current year 27.96
Extreme 27.96
43.5
1 year 27.96
Extreme 27.96
49.99
3 years 26.51
Extreme 26.51
88.9
5 years 26.51
Extreme 26.51
124
10 years 26.51
Extreme 26.51
124
Manager TitleAgeSince
Chief Executive Officer 56 10/11/2016
Director of Finance/CFO 76 01/01/2021
Human Resources Officer - -
Director TitleAgeSince
Director/Board Member 56 10/11/2016
Director/Board Member 76 10/11/2016
Chairman 73 16/11/2020
Change 5-day change 1-year change 3-year change Capi.($)
-1.54%-2.30%+11.01%-34.36% 6.86M
-2.41%+0.14%+39.53%+154.43% 1,010B
+1.07%+3.48%+53.75%+50.64% 580B
+1.32%+0.22%+18.35%+65.35% 402B
+0.77%0.00%+19.99%+16.80% 330B
-1.42%-1.44%+45.50%+8.37% 294B
-0.85%-2.86%+22.05%+13.80% 280B
+0.44%+3.48%+24.48%+34.39% 281B
+1.66%+1.20%-44.67%-47.49% 197B
+0.32%+1.61%+19.48%+63.42% 192B
Average -0.06%+0.66%+20.95%+32.53% 356.7B
Weighted average by Cap. -0.33%+1.00%+29.84%+66.16%

Financials

2024 2025
Net sales 1.51K 15.87 13.72 12.64 11.84 22.21 22.54 149.8 58.28 734.3 59.57 58.3 2.54K 769.53 8.09 6.99 6.44 6.04 11.32 11.49 76.36 29.71 374.3 30.37 29.72 1.3K
Net income 10.27M 108K 93.33K 86.01K 80.57K 151K 153K 1.02M 397K 5M 405K 397K 17.31M -202M -2.12M -1.83M -1.69M -1.58M -2.97M -3.01M -20.04M -7.79M -98.21M -7.97M -7.8M -340M
Net Debt 441M 4.63M 4M 3.69M 3.46M 6.48M 6.58M 43.73M 17.01M 214M 17.39M 17.02M 743M 397M 4.18M 3.61M 3.33M 3.12M 5.85M 5.93M 39.43M 15.34M 193M 15.68M 15.35M 670M
Logo Vineet Laboratories Limited
Vineet Laboratories Limited is an India-based company engaged in the business of drug intermediates and bulk drugs. The Company specializes in pharmaceutical intermediates and fine chemicals. Its active pharmaceutical ingredient (API) intermediates products include Lopinavir, Ritonavir, Efavirenz, Nadolol, Glimepiride, Celecoxib, and Piroctone Olanine. Its fine chemicals and reagents include Isopropyl-beta-D-thiogalactopyranoside, 4-Nitrophenyl phosphate disodium salt, 5-Bromo-4-chloro-3-indolyl-beta-D-galactopyranoside (X-Gal), 5-Acetyl thiophene-2-carboxilic acid, n-Butyl Lithium, n-Butyl magnesium chloride, 3-Furaldehyde, 3-bromofuran, 1-methyl-imidazole-2-carboxaldehyde, 6-Aminouracil, Ethyldiazo acetate, and Phenylboronic acid. The Company also exports API intermediates, fine chemicals, and custom synthesis molecules.
Employees
57
Date Price Change Volume
12/06/26 33.97 -1.54% 35,451
11/06/26 34.50 +3.76% 20,821
10/06/26 33.25 -1.36% 10,060
09/06/26 33.71 +0.96% 13,503
08/06/26 33.39 -3.97% 41,251
  1. Stock Market
  2. Stocks
  3. VINEETLAB Stock
- 40% : Our Best Subscriber-Only Tools to Spot Tomorrow’s Top Investments!
d
:
:
SEIZE THE OFFER!